Cargando…
Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection
Advanced heart failure is a growing problem for which the best treatment is cardiac transplantation. However, the shortage of donors’ hearts made left ventricular assist devices as destination therapy (DT-LVAD) a highly recommended alternative: they improved mid-term prognosis as well as patients’ q...
Autores principales: | Melendo-Viu, María, Dobarro, David, Raposeiras Roubin, Sergio, Llamas Pernas, Carmen, Moliz Cordón, Candela, Vazquez Lamas, Miriam, Piñón Esteban, Miguel, Varela Martínez, Maria Ángela, Abu Assi, Emad, Pita Romero, Rafael, Legarra Calderón, Juan José, Íñiguez Romo, Andrés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144236/ https://www.ncbi.nlm.nih.gov/pubmed/37109593 http://dx.doi.org/10.3390/life13041065 |
Ejemplares similares
-
Safety of digoxin in nonagenarian patients with atrial fibrillation: lessons from the Spanish Multicenter Registry
por: Domínguez-Erquicia, Pablo, et al.
Publicado: (2021) -
Bleeding risk assessment in elderly patients with acute coronary syndrome
por: Riobóo-Lestón, Lucía, et al.
Publicado: (2019) -
New Cancer Diagnosis After Bleeding in Anticoagulated Patients With Atrial Fibrillation
por: Raposeiras Roubín, Sergio, et al.
Publicado: (2020) -
Current status of NADPH oxidase research in cardiovascular
pharmacology
por: Rodiño-Janeiro, Bruno K, et al.
Publicado: (2013) -
Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO‐D registry
por: Dobarro, David, et al.
Publicado: (2023)